Abstract:Background: The predominant immune cells in solid tumors are M2-like tumor-associated macrophages (M2-like TAMs), which significantly impact the promotion of epithelial-mesenchymal transition (EMT) in tumors, enhancing stemness and facilitating tumor invasion and metastasis. However, the contribution of M2-like TAMs to tumor progression in gallbladder cancer (GBC) is partially known. Methods: Immunohistochemistry was used to evaluate the expression of M2-like TAMs and cancer stem cell (CSC) markers in 24 pairs of GBC and adjacent noncancerous tissues from patients with GBC. Subsequently, GBC cells and M2-like TAMs were co-cultured to examine the expression of CSC markers, EMT markers, and migratory behavior. Proteomics was performed on the culture supernatant of M2-like TAMs. The mechanisms underlying the induction of EMT, stemness, and metastasis in GBC by M2-like TAMs were elucidated using proteomics and transcriptomics. GBC cells were co-cultured with undifferentiated macrophages (M0) and analyzed. The therapeutic effect of gemcitabine combined with a chemokine (C-C motif) receptor 2 (CCR2) antagonist on GBC was observed in vivo. Results: The expression levels of CD68 and CD163 in M2-like TAMs and CD44 and CD133 in gallbladder cancer stem cells (GBCSCs) were increased and positively correlated in GBC tissues compared with those in neighboring noncancerous tissues. M2-like TAMs secreted a significant amount of chemotactic cytokine ligand 2 (CCL2), which activated the MEK/extracellular regulated protein kinase (ERK) pathway and enhanced SNAIL expression after binding to the receptor CCR2 on GBC cells. Activation of the ERK pathway caused nuclear translocation of ELK1, which subsequently led to increased SNAIL expression. GBCSCs mediated the recruitment and polarization of M0 into M2-like TAMs within the GBC microenvironment via CCL2 secretion. In the murine models, the combination of a CCR2 antagonist and gemcitabine efficiently inhibited the growth of subcutaneous tumors in GBC. Conclusions: The interaction between M2-like TAMs and GBC cells is mediated by the chemokine CCL2, which activates the MEK/ERK/ELK1/SNAIL pathway in GBC cells, promoting EMT, stemness, and metastasis. A combination of a CCR2 inhibitor and gemcitabine effectively suppressed the growth of subcutaneous tumors. Consequently, our study identified promising therapeutic targets and strategies for treating GBC.

Abnormal Inflammatory Status Promotes Lymphatic Metastasis of Gallbladder Cancer Cells Through the CACUL1/NRF2/ITGBL1/ITGA9/VEGF-C Pathway

Chronic Inflammation and Gallbladder Cancer.

Single-cell dissection of remodeled inflammatory ecosystem in primary and metastatic gallbladder carcinoma

CCL18 secreted from M2 macrophages promotes migration and invasion via the PI3K/Akt pathway in gallbladder cancer

Prognostic Significance of Immune Cells in the Tumor Microenvironment and Peripheral Blood of Gallbladder Carcinoma Patients

Progress of the Molecular Mechanisms Research of Gallbladder Cancer Lymphatic Metastasis

Identification of Cd146 Expression, Angiogenesis, and Lymphangiogenesis As Progression, Metastasis, and Poor-Prognosis Related Markers for Gallbladder Adenocarcinoma

Circulating Levels of Inflammatory Proteins and Survival in Patients with Gallbladder Cancer

FGF19 and FGFR4 promotes the progression of gallbladder carcinoma in an autocrine pathway dependent on GPBAR1-cAMP-EGR1 axis

RNA sequencing revealed the multi-stage transcriptome transformations during the development of gallbladder cancer associated with chronic inflammation

Gallbladder cancer-associated fibroblasts promote vasculogenic mimicry formation and tumor growth in gallbladder cancer via upregulating the expression of NOX4, a poor prognosis factor, through IL-6-JAK-STAT3 signal pathway

Annexin A4-nuclear factor-κB feedback circuit regulates cell malignant behavior and tumor growth in gallbladder cancer

Identification of Metastasis-Associated Proteins Involved in Gallbladder Carcinoma Metastasis by Proteomic Analysis and Functional Exploration of Chloride Intracellular Channel 1

Inflammation: a Key Factor of Gallbladder Cancer

M2-like tumor-associated macrophage-secreted CCL2 facilitates gallbladder cancer stemness and metastasis

Microcystin-leucine-arginine Promotes the Development of Gallbladder Carcinoma Via Regulating ELAC2.

Overexpression of Thy1 and ITGA6 is associated with invasion, metastasis and poor prognosis in human gallbladder carcinoma

Ciap1 Promotes Proliferation and Migration and Prevents Apoptosis in Gallbladder Cancer in Vitro

Mybl2 is A Potential Prognostic Marker That Promotes Cell Proliferation in Gallbladder Cancer

Upregulation of Long Non-Coding RNA LINC00152 by SP1 Contributes to Gallbladder Cancer Cell Growth and Tumor Metastasis Via PI3K/AKT Pathway.

Prognostic and Clinicopathological Significance of X-Box-Binding Protein 1 and N-Acetyltransferase 1 in Gallbladder Cancer